{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:49:41Z","timestamp":1759178981145},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijcard.2016.01.185","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T02:55:29Z","timestamp":1452826529000},"page":"308-309","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke \u2014 Effect of lost-to-follow-up and withdrawal of consent"],"prefix":"10.1016","volume":"207","author":[{"given":"Mikael","family":"Dellborg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.01.185_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2009.01.049","article-title":"The significance of patent foramen ovale: a current review of associated conditions and treatment","volume":"134","author":"Johansson","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0020","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjcard.2014.12.051","article-title":"Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale","volume":"115","author":"Patti","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2016.01.185_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0035","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","article-title":"Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials","volume":"22","author":"Nagaraja","year":"2013","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0045","unstructured":"http:\/\/www.tctmd.com\/show.aspx?id=132727, (accessed on nov 10, 2015)"},{"issue":"1","key":"10.1016\/j.ijcard.2016.01.185_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome. ATLASACS 2\u2013TIMI 51 Investigators","volume":"366","author":"Mega","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0055","unstructured":"http:\/\/www.medscape.com\/viewarticle\/764433 Miller R: Missing Data Lead FDA Panel to Vote Against Rivaroxaban for ACS"},{"key":"10.1016\/j.ijcard.2016.01.185_bb0060","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.01.185_bb0065","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T13:24:05Z","timestamp":1556371445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731630184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":13,"alternative-id":["S016752731630184X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.185","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke \u2014 Effect of lost-to-follow-up and withdrawal of consent","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}